Supplementary Figure S1 from Phase I Trial of Ganitumab Plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in RhabdomyosarcomaSrivandana Akshintala,R. Taylor Sundby,Donna Bernstein,John W. Glod, Rosandra N. Kaplan,Marielle E. Yohe,Andrea M. Gross,Joanne Derdak,Haiyan Lei,Alexander Pan,Eva Dombi,Isabel Palacio-Yance,Kailey R. Herrera,Markku M. Miettinen, Helen X. Chen,Seth M. Steinberg, Lee J. Helman,Leo Mascarenhas,Brigitte C. Widemann,Fariba Navid,Jack F. Shern,Christine M. Heskecrossref（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
